ELI LILLY & Co (LLY) stock

LLYNYSEPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 19/3024% above fair value

$1443.50+16.22 (+1.14%)

Close on Nov 13, 2026Market cap $1.36TP/E 46.9Yield 0.43%

Eli Lilly EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Eli Lilly's EV/EBITDA was 37.4× on Nov 11, 2026, against 39.6× a year earlier. Over the last 5 years it ranged from 27.6× to 86.8×, with a median of 41.4×.

EV/EBITDA at the end of each year

Period	Period end	Value	Change (pts)
2026	Nov 11, 2026	37.4×	−2.2
2025	Dec 31, 2025	39.5×	−18.4
2024	Dec 31, 2024	58.0×	−9.3
2023	Dec 29, 2023	67.3×	+26.6
2022	Dec 30, 2022	40.7×	+9.8
2021	Dec 31, 2021	30.9×	+10.1
2020	Dec 31, 2020	20.7×	−2.4
2019	Dec 31, 2019	23.1×	−2.0
2018	Dec 31, 2018	25.1×	+3.9
2017	Dec 29, 2017	21.2×	+3.1
2016	Dec 30, 2016	18.1×	−3.0
2015	Dec 31, 2015	21.1×	+11.0
2014	Dec 31, 2014	10.1×	+1.6
2013	Jan 31, 2013	8.5×	+0.7
2012	Dec 31, 2012	7.8×	–